President Trump on Monday fired all three Democrats on the Privacy and Civil Liberties Oversight Board (PCLOB), bringing much ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Parkinson's disease affects not only muscle movement but also the mental health of those diagnosed. While there is no cure, staying active is key to managing the disease.

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, according to a new Irish study. The findings show that over eight in ten ...

Following “positive” top-line phase II trial results, neurodegenerative disease house Alterity Therapeutics (ASX:ATH) will ...

Robert F. Kennedy Jr. has spasmodic dysphonia, a voice disorder caused by a malfunction in the brain. Here’s what to know.

Bajaj Healthcare has received approval from India's Drug Controller General to manufacture Pimavanserin, a drug for Parkinson's-related hallucinations and delusions. Pimavanserin, already popular in ...

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.